-transparent.png){kind=logo}
Twenty patients with recurrent or metastatic squamous cell carcinoma of the cervix were treated with continuous-infusion vinblastine sulfate. Two patients (10%) had partial responses of 4 and 7 months' duration. Neutropenia was dose limiting. Vinblastine sulfate given by continuous infusion has limited activity in this malignancy.
Related Publications
J J Kavanagh, and
L J Copeland, and
D M Gershenson, and
P B Saul, and
J T Wharton, and
F N Rutledge
November 1984,
Cancer treatment reports,
J J Kavanagh, and
L J Copeland, and
D M Gershenson, and
P B Saul, and
J T Wharton, and
F N Rutledge
February 1987,
Gynecologic oncology,
J J Kavanagh, and
L J Copeland, and
D M Gershenson, and
P B Saul, and
J T Wharton, and
F N Rutledge
January 1984,
Anticancer research,
J J Kavanagh, and
L J Copeland, and
D M Gershenson, and
P B Saul, and
J T Wharton, and
F N Rutledge
March 1990,
European journal of cancer (Oxford, England : 1990),
J J Kavanagh, and
L J Copeland, and
D M Gershenson, and
P B Saul, and
J T Wharton, and
F N Rutledge
October 1983,
American journal of clinical oncology,
J J Kavanagh, and
L J Copeland, and
D M Gershenson, and
P B Saul, and
J T Wharton, and
F N Rutledge
July 1989,
Investigational new drugs,
J J Kavanagh, and
L J Copeland, and
D M Gershenson, and
P B Saul, and
J T Wharton, and
F N Rutledge
June 1984,
Cancer treatment reports,
J J Kavanagh, and
L J Copeland, and
D M Gershenson, and
P B Saul, and
J T Wharton, and
F N Rutledge
October 1990,
American journal of clinical oncology,
J J Kavanagh, and
L J Copeland, and
D M Gershenson, and
P B Saul, and
J T Wharton, and
F N Rutledge
June 1987,
American journal of clinical oncology,
J J Kavanagh, and
L J Copeland, and
D M Gershenson, and
P B Saul, and
J T Wharton, and
F N Rutledge
June 1997,
Cancer,
